Fiera Capital Corp Argenx Se Transaction History

Fiera Capital Corp

$31.6 Billion
Q3 2024

A detailed history of Fiera Capital Corp transactions in Argenx Se stock. As of the latest transaction made, Fiera Capital Corp holds 158,353 shares of ARGX stock, worth $98.8 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

158,353

Previous 165,595 4.37%

Holding current value

$98.8 Million

Previous $71.2 Million 20.6%

% of portfolio

0.27%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$434.22 - $551.9 $3.14 Million - $4 Million	-7,242 Reduced 4.37%	158,353 $85.9 Million
Q2 2024 Aug 01, 2024	BUY	$356.01 - $451.55 $1.25 Million - $1.58 Million	3,506 Added 2.16%	165,595 $71.2 Million
Q1 2024 Aug 22, 2024	SELL	$356.95 - $413.29 $1.25 Million - $1.45 Million	-3,506 Reduced 2.12%	162,089 $63.8 Million
Q1 2024 May 01, 2024	SELL	$356.95 - $413.29 $481,525 - $557,528	-1,349 Reduced 0.83%	162,089 $63.8 Million
Q4 2023 Aug 22, 2024	BUY	$338.91 - $506.01 $496,164 - $740,798	1,464 Added 0.9%	163,438 $62.2 Million
Q4 2023 Feb 08, 2024	BUY	$338.91 - $506.01 $496,164 - $740,798	1,464 Added 0.9%	163,438 $62.2 Million
Q3 2023 Aug 22, 2024	SELL	$369.35 - $548.43 $1.34 Million - $1.99 Million	-3,621 Reduced 2.19%	161,974 $79.6 Million
Q3 2023 Nov 09, 2023	BUY	$369.35 - $548.43 $1.38 Million - $2.05 Million	3,731 Added 2.36%	161,974 $79.6 Million
Q2 2023 Aug 09, 2023	SELL	$360.14 - $422.58 $1.15 Million - $1.35 Million	-3,199 Reduced 1.98%	158,243 $61.7 Million
Q1 2023 Apr 26, 2023	SELL	$334.23 - $403.65 $908,771 - $1.1 Million	-2,719 Reduced 1.66%	161,442 $60.2 Million
Q4 2022 Feb 08, 2023	SELL	$342.17 - $402.31 $329,509 - $387,424	-963 Reduced 0.58%	164,161 $62.2 Million
Q3 2022 Nov 03, 2022	SELL	$343.2 - $395.75 $946,545 - $1.09 Million	-2,758 Reduced 1.64%	165,124 $54.9 Million
Q2 2022 Aug 10, 2022	SELL	$269.58 - $378.88 $605,746 - $851,343	-2,247 Reduced 1.32%	167,882 $63.6 Million
Q1 2022 May 09, 2022	BUY	$254.45 - $351.06 $16.3 Million - $22.4 Million	63,907 Added 60.16%	170,129 $53.6 Million
Q4 2021 Feb 08, 2022	SELL	$272.01 - $353.03 $853,023 - $1.11 Million	-3,136 Reduced 2.87%	106,222 $37.2 Million
Q3 2021 Nov 12, 2021	SELL	$295.0 - $350.58 $500,910 - $595,284	-1,698 Reduced 1.53%	109,358 $33 Million
Q2 2021 Aug 11, 2021	SELL	$257.11 - $319.92 $638,147 - $794,041	-2,482 Reduced 2.19%	111,056 $25 Million
Q1 2021 May 11, 2021	SELL	$268.3 - $380.31 $1.02 Million - $1.44 Million	-3,795 Reduced 3.23%	113,538 $31.3 Million
Q4 2020 Feb 09, 2021	BUY	$248.13 - $308.36 $196,518 - $244,221	792 Added 0.68%	117,333 $34.5 Million
Q3 2020 Nov 12, 2020	SELL	$215.51 - $272.51 $852,773 - $1.08 Million	-3,957 Reduced 3.28%	116,541 $30.6 Million
Q2 2020 Aug 07, 2020	SELL	$127.44 - $232.72 $318,982 - $582,498	-2,503 Reduced 2.03%	120,498 $27.1 Million
Q1 2020 May 08, 2020	BUY	$108.83 - $165.23 $228,434 - $346,817	2,099 Added 1.74%	123,001 $16.2 Million
Q4 2019 Feb 06, 2020	BUY	$106.59 - $164.21 $12.9 Million - $19.9 Million	120,902 New	120,902 $19.4 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Fiera Capital Corp with notifications on news.

Account

Fiera Capital Corp Argenx Se Transaction History